Lisata Therapeutics, Inc. (NASDAQ:LSTA) Q3 2025 Earnings Call Transcript

Lisata Therapeutics, Inc. (NASDAQ:LSTA) Q3 2025 Earnings Call Transcript November 6, 2025

Lisata Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.49, expectations were $-0.54.

Operator: Welcome to the Lisata Therapeutics Third Quarter 2025 Financial Results and Business Update Conference Call. [Operator Instructions] As a reminder, this call is being recorded today, Thursday, November 6, 2025. I will now turn the call over to John Menditto, Vice President of Investor...